EPS Bio Technology Corp.

Research EPS Bio Technology Corp. (4183.TWO) on Bullrun: market cap TWD 337.96M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker4183.TWO
ExchangeTWO
CountryTaiwan
SectorHealthcare
IndustryMedical Devices
CurrencyTWD
Market capTWD 337.96M
Financial periodQ2 2026
RevenueTWD 105.58M
Net income-TWD 1.47M
Free cash flowTWD 38.30M
Gross margin18.7%

Valuation Snapshot

latest market cap is TWD 337.96M.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	TWD 337.96M	n/a	n/a	0.67

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.67 TWD.

About EPS Bio Technology Corp.

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Apex Biotechnology Corp. (1733.TW) Health & Life Co., Ltd. (1781.TWO) Hi-Clearance Inc. (1788.TWO) Radiant Innovation Inc. (3373.TWO) Wellell Inc. (4106.TW) Rossmax International Ltd. (4121.TWO) United Orthopedic Corporation (4129.TWO) Dynamic Medical Technologies Inc. (4138.TWO) OK Biotech Co., Ltd. (4155.TW) Bioptik Technology Incorporation (4161.TWO) AmCad BioMed Corporation (4188.TWO) S&S Healthcare Holding Ltd. (4198.TWO)

Frequently asked questions

What is EPS Bio Technology Corp.'s market cap?

EPS Bio Technology Corp.'s market capitalization is TWD 337.96M.